Clinical trial
Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary…
NCT00201708 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00201708 |
|---|---|
| Title | Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer |
| Official title | Phase II Randomized Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide (AC) in Axillary Node-Positive Breast Cancer |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Doxorubicin, Cyclophosphamide (AC) |
| Enrollment | 56 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Feb 1, 2014 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 2, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: